Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Practice Guidelines for Parkinson's disease.

Mitsutoshi Yamamoto1

  • 1Department of Neurology, Kagawa Prefectural Central Hospital, 5-4-16 Bancho, Takamatsu 760-8557, Japan. dyama@mail.netwave.or.jp

Parkinsonism & Related Disorders
|August 14, 2003
PubMed
Summary

Practice Guidelines (PG) are decision-support tools, not absolute rules. Effective clinical decision-making integrates PGs with patient preferences and healthcare contexts, emphasizing the need for updated evidence and EBM principles.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid Eye Movement Sleep Behavior Disorder-like Symptoms Due to Arousal Responses Associated with Severe Obstructive Sleep Apnea-hypopnea.

Internal medicine (Tokyo, Japan)·2021
Same author

Non-motor symptoms depending on motor severity in Japanese patients with Parkinson's disease: A multicenter cross-sectional study.

Journal of the neurological sciences·2020
Same author

Repeated anti-N-methyl-D-aspartate receptor encephalitis coexisting with anti-myelin oligodendrocyte glycoprotein antibody-associated diseases: A case report.

Multiple sclerosis and related disorders·2019
Same author

Long-Term Selegiline Monotherapy for the Treatment of Early Parkinson Disease.

Clinical neuropharmacology·2019
Same author

Pharmacological treatment of early Parkinson's disease.

Nihon rinsho. Japanese journal of clinical medicine·2018
Same author

A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease.

Clinical neuropharmacology·2017

Area of Science:

  • Medical Practice
  • Clinical Decision-Making
  • Evidence-Based Medicine

Background:

  • Practice Guidelines (PG) serve as tools to support clinical decisions, not as infallible directives.
  • Clinical decisions integrate PGs with patient preferences and national healthcare systems.
  • The applicability of PG treatment methods, even those based on high-level evidence, may vary among individual patients.

Purpose of the Study:

  • To emphasize that Practice Guidelines are not absolute rules.
  • To highlight the importance of considering patient preferences and healthcare systems in clinical decisions.
  • To underscore the necessity of critically evaluating PGs and seeking updated evidence.

Main Methods:

  • Critical appraisal of Practice Guidelines.

Related Experiment Videos

  • Integration of patient-specific factors into clinical decision-making.
  • Literature search for updated evidence to supplement PGs.

    • Main Results:

    • Practice Guidelines are valuable but require careful interpretation within specific contexts.
    • Patient preferences and socio-economic factors significantly influence clinical decision-making.
    • Continuous literature review is essential to ensure the use of the most current evidence.

    Conclusions:

    • Practice Guidelines should be developed considering local conditions and potential biases (e.g., industry involvement).
    • Evidence-Based Medicine (EBM) principles necessitate ongoing literature assessment to address gaps in PGs.
    • Clinicians must actively seek the latest evidence to complement published guidelines and ensure optimal patient care.